Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 7, 2009 - Issue 12
Submit an article Journal homepage
40
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Oral contraceptives and venous thromboembolism: identifying the safest option

Olivia Wu Division of Community Based Sciences, Faculty of Medicine, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, UK. [email protected]
Pages 1513-1516 | Published online: 10 Jan 2014

References

  • van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case–control study. BMJ339, b2921 (2009).
  • Rathbun S. Venous thromboembolism in women. Vasc. Med.13, 255–266 (2008).
  • Gallo MF, Nanda K, Grimes DA, Scjulz KF. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst. Rev. (2), CD003989 (2005).
  • Kemmeren IM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. Br. Med. J.323, 1–7 (2001).
  • World Health Organiszation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolism disease and combined oral contraceptives: results of international multicentre case–control study. Lancet346, 1575–1582 (1995).
  • Vasilakis-Scaramozzo C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet358, 1427–1429 (2001).
  • Seaman HE, deVries CS, Farmer RDT. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette®): observational studies using the UK General Practice Research Database. Pharmacoepidemiol. Drug Saf.13, 427–436 (2004).
  • Dinger JC, Heinemann LA, Kuhl-habich D. The safety of drospirenone-containing oral contraceptives: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception110, 587–93 (2007).
  • Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ339, b2890 (2009).
  • Pomp ER, le Cessie S, Rosendaal FR, Doggen CJM. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br. J. Haematol.139, 289–296 (2007).
  • Wu O, Robertson L, Langhorne P et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thromb. Haemost.94, 17–25 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.